Sutro Biopharma, Inc. (STRO)

13.50 +0.43 (+3.29%) USD  |  NASDAQ  |  Jan 16, 11:14
More

Sutro Biopharma Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for STRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Daré Bioscience, Inc. Upgrade
Syndax Pharmaceuticals, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade